Injection 結果共4筆

The number of approved overseas Chinese and foreign investments in Taiwan decreased by 8.89% to 2,102 cases in the first 11 months of 2023 compared to the same period last year. However, the investment amount from these sources reached US$10.79 billion (NT$323.7 billion), the second-highest in the past 15 years, with significant contributions from the offshore wind power sector. French company TotalEnergies Renewables SAS and British firm OSW Investments Taiwan JVCO 2 Limited increased their capital in Haiding Two International Investment Co., Ltd. by NT$5.03 billion. New companies established during this period amounted to 1,124 cases, with an investment value of US$680 million (NT$20.37 billion). Investments from Southeast Asian countries increased notably, with 609 cases, a 41.3% year-on-year increase, and a monetary surge of 25.2% to US$2.52 billion (NT$75.68 billion), mainly from Singapore, Thailand, and Malaysia. However, Chinese investments in Taiwan declined, with only 24 approved cases, a 45.45% decrease from the previous year, and investment figures dropping by 21.65% to US$27.38 million (NT$820 million). On the other hand, overseas investments from Taiwan increased, with a moderate rise in approved cases by 2.44% to 504 and a substantial annual increase of 145.61% in investment total to US$22.81 billion (NT$684.42 billion). Key overseas investments included TSMC’s US$8 billion capital injection into its Arizona subsidiary and a €3.5 billion investment in Germany’s ESMC GmbH. Foxconn Technology Group also made a significant investment of US$8 billion in its Singapore subsidiary, and Yang Ming Marine Transport Corp. invested a similar amount in Singapore-based Yang Ming (Singapore) Pte. Ltd.

食藥署今（1）日公布藥品回收，包括溫士頓醫藥公司的「溫士頓鹽酸四環素眼藥膏 Tetracycline Ophthalmic Ointment“Winston”」以及台裕化學製藥廠公司的「台裕久克坦注射液（硫辛酸）THIOCTAN INJECTION (THIOCTIC ACID) ＂TAI YU”」兩項藥品各一個批號都要進行回收。食藥署食藥署藥品組科長洪國登表示，「溫士頓眼藥膏」在一月時候就曾因為有變色狀況回收兩萬四千支，這一次廠商擴大檢查後，發現還有一批顏色異常，同時主成份含量不足。

食藥署今（27）日公布藥品回收，「安星製藥股份有限公司」的「＂安星＂生理食鹽水注射液 SODIUM CHLORIDE INJECTION ＂ASTAR”」批號2003061因為有PH值降低的狀況，因此食藥署要求下架回收約3.3萬袋。

食藥署藥品組今（13）日公布藥品回收資訊，永信藥品工業股份有限公司的「永信達比黴素注射劑TAPIMYCIN INJECTION ＂YUNG SHIN”」因為在批號TYI4 N005藥品有發現玻璃碎片混入藥品內，因此緊急啟動回收，數量大約有兩萬七千多支。